Key Market Drivers, Trends, and Forecast for the Global Semi-Solid Dosage Contract Manufacturing Industry
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Semi-Solid Dosage Contract Manufacturing Market Valued at Present and by 2029?
The market size for contract manufacturing of semi-solid dosages has seen swift expansion recently. It’s projected to increase from $16.23 billion in 2024 to $17.97 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%. This growth observed in the historic period is largely due to the rise in the elderly population, escalated global healthcare spending, a strong demand upsurge for hormone replacement therapies, heightened awareness about skincare health, and the escalating presence of biologics and biosimilars in topical forms.
The market size of the semi-solid dosage contract manufacturing is anticipated to have dynamic growth over the coming years, reaching a value of $26.76 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. Various factors contribute to this predicted growth during the forecast period, such as the increasing need for dermatological treatments, the rising prevalence of enduring skin conditions, broader production of generic drugs, cost-effectiveness of contract manufacturing, and heightened demand for topical drug delivery. Upcoming trends in this timeline comprise advancements in formulation technologies, requirements for adaptable manufacturing capacity, embracing quality-by-design methods, technological progress in semi-solid processing equipment, and an elevated need for the accelerated development of drugs.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25899&type=smp
#What Drivers Are Influencing Growth In The Semi-Solid Dosage Contract Manufacturing Market?
The surge in skin disorders is predicted to be a significant factor propelling the expansion of the semi-solid dosage contract manufacturing market. Skin conditions encompass issues that compromise the look or function of the skin, frequently leading to symptoms like irritation, inflammation, or abnormal skin growths. The escalation of environmental pollution, which impairs the skin’s protective barrier, resulting in heightened sensitivity, allergic reactions, and chronic skin issues, is prompting the rise of these skin disorders. The contract manufacturing of semi-solid dosages aids in skin disease prevention by ensuring consistent, high-grade topical treatments that effectively promote and enhance skin wellbeing. For example, Cancer Research UK, a cancer research institution based in the UK, predicted in February 2023 that the average annual rate of melanoma skin cancer in the UK will likely escalate from approximately 20,800 cases in the 2023–2025 period to about 26,500 cases in the 2038–2040 period. Hence, the rampant occurrence of skin disorders is stimulating the growth of the semi-solid dosage contract manufacturing market.
What Are The Main Segments Identified In The Semi-Solid Dosage Contract Manufacturing Market Research?
The semi-solid dosage contract manufacturing market covered in this report is segmented –
1) By Type: Topical, Transdermal, Oral
2) By Material Type: Synthetic, Natural, Bio-Based
3) By Company Size: Large Size Companies, Medium And Small Size Companies, Other Company Sizes
4) By Therapeutic Application: Dermatology, Pain Management, Hormonal Therapy, Wound Care, Ophthalmic Disorders, Other Therapeutic Applications
5) By End Use: Pharmaceutical Companies, Cosmeceutical Companies, Other End Uses
Subsegments:
1) By Topical: Creams, Ointments, Gels, Lotions, Pastes, Foams
2) By Transdermal: Transdermal Gels, Transdermal Creams, Transdermal Sprays, Transdermal Emulsions, Medicated Patches
3) By Oral: Oral Gels, Oral Pastes, Oral Suspensions, Oral Emulsions, Oral Jellies
What Long-Term Trends Are Likely To Affect The Semi-Solid Dosage Contract Manufacturing Market?
Main players in the semi-solid dosage contract manufacturing market, such as LGM Pharma, are concentrating their efforts on strategic investments. These investments are substantial financial commitments designed to solidify and build upon the company’s primary objectives, future expansion plans, and market positioning. In March 2025, LGM Pharma, a US-based semi-solid dosage manufacturing contractor, publicized an investment of more than $6 million to extend their manufacturing facility in Rosenberg, Texas. This investment was designed to scale up production of various drug formulations, such as liquid, suspension, semi-solid, and suppositories. The purpose is to keep up with the rising domestic pharmaceutical manufacturing demands. This fits perfectly into LGM Pharma’s current growth in prescription drug development, including 505(b)(2) and ANDA programs. The modifications at their Rosenberg facility will ensure greater productivity while adhering to FDA standards and good manufacturing practices. The plant will maintain its operations during the expansion without any disruption.
Which Companies Play A Key Role In The Development Of The Semi-Solid Dosage Contract Manufacturing Market?
Major companies operating in the semi-solid dosage contract manufacturing market are Eurofins Scientific SE, The Lubrizol Corporation, Grunenthal, Recipharm AB, Piramal Pharma Solutions Inc., Cambrex Corporation, Sharp Services, ANI Pharmaceuticals, Pierre Fabre SA, Aurigene Pharmaceutical Services Limited, DPT Laboratories Ltd., Douglas Pharmaceuticals Ltd., Mission Pharmacal Co., Pace Analytical Life Sciences LLC, Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Fermion Oy, Ferndale Pharma Group, Sterling Pharmaceutical Services LLC, Aphena Pharma Solutions Inc., Eubioco LLC, LGM Pharma LLC, Madras Pharmaceuticals, Quality CDMO, Axxelent Pharma Science.
Get The Full Report Here:
What Are The Key Regional Developments Shaping The Semi-Solid Dosage Contract Manufacturing Market?
North America was the largest region in the semi-solid dosage contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the semi-solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25899&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
